Albena Lederer Selected Research

Chymotrypsin

1/2021

Molecular Dynamics-Guided Design of a Functional Protein-ATRP Conjugate That Eliminates Protein-Protein Interactions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Albena Lederer Research Topics

Disease

3	Neoplasms (Cancer) 01/2020 - 04/2015
1	Alzheimer Disease (Alzheimer's Disease) 12/2023
1	Fibrosis (Cirrhosis) 10/2021
1	Inflammation (Inflammations) 10/2021
1	Liver Cirrhosis (Hepatic Cirrhosis) 10/2021
1	Exocrine Pancreatic Insufficiency 01/2021

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 10/2021 - 01/2019
1	Amyloid (Amyloid Fibrils)IBA 12/2023
1	Peptides (Polypeptides)IBA 12/2023
1	Therapeutic UsesIBA 10/2021
1	Carbon Tetrachloride (Tetrachloromethane)IBA 10/2021
1	CollagenIBA 10/2021
1	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 10/2021
1	EnzymesIBA 01/2021
1	Chymotrypsin FDA Link 01/2021
1	LectinsIBA 01/2019
1	StreptavidinIBA 01/2019
1	SurvivinIBA 01/2019
1	Small Interfering RNA (siRNA)IBA 01/2019
1	Drug CarriersIBA 04/2015
1	Folic Acid (Vitamin M)FDA LinkGeneric 04/2015

Therapy/Procedure

1	Therapeutics 01/2020